Core Insights - Iridex Corporation will host a special call on April 16, 2025, to discuss its strategic vision following a recent investment from Novel [1] - The conference call will begin at 2:00 p.m. PT / 5:00 p.m. ET, and investors can participate by dialing 888-596-4144 with conference ID: 9584140 [2] - Iridex is a leader in developing laser-based medical systems for ophthalmology, focusing on treatments for glaucoma and retinal diseases [3] Company Overview - Iridex Corporation specializes in innovative laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market [3] - The company's proprietary MicroPulse® technology offers a differentiated laser treatment for sight-threatening eye conditions [3] - Iridex's products are marketed in over 100 countries, with a direct sales force in the United States and independent distributors internationally [3]